Autism spectrum disorders and coexisting disorders in a nationwide Swedish twin study by Lundström, Sebastian et al.
  
 
 
 
 
 
 
 
 
 
 
 
This is the peer reviewed version of the following article:  
 
J Child Psychol Psychiatry. 2015 Jun;56(6):702-10 
 
which has been published in final form at  
 
http://dx.doi.org/10.1111/jcpp.12329 
 
 
This article may be used for non-commercial purposes in 
accordance With Wiley Terms and Conditions for self-archiving 
http://olabout.wiley.com/WileyCDA/Section/id-820227.html 
 
1 
 
Autism Spectrum Disorders and Coexisting Disorders in a Nationwide 
Swedish Twin Study 
 
Sebastian Lundström, PhD
1,2,3
, Abraham Reichenberg, PhD 
4
, Jonas Melke, PhD 
5
, Maria 
Råstam, MD, PhD
6
, Nóra Kerekes, PhD
1,3
, Paul Lichtenstein, PhD
7
, Christopher Gillberg, 
MD, PhD
2
, Henrik Anckarsäter, MD, PhD
1
. 
1 Centre for Ethics, Law and Mental Health (CELAM), University of Gothenburg, Sweden 
2 Gillberg Neuropsychiatry Centre, University of Gothenburg, Sweden 
3 Swedish Prison and Probation Service, R&D Unit, Gothenburg, Sweden  
4 Departments of Psychiatry and Preventive Medicine, Mount Sinai School of Medicine, New 
York, NY 
5 Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska 
Academy at Göteborg University 
6 Department of Clinical Sciences, Child and Adolescent Psychiatry, Lund University, Lund, 
Sweden 
7 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 
Sweden 
  
2 
 
Abstract 
Introduction  
Evidence from twin and molecular genetic studies is accumulating that Autism Spectrum 
Disorder (ASD) shares substantial etiological factors with other disorders. This is mirrored in 
clinical practice where ASD without coexisting disorders is rare. The present study aims to 
examine the range of coexisting disorders in ASD in a genetically informative cohort.  
Methods 
Parents of all Swedish 9-year-old twins born between 1992 and 2001 (n= 19,130) underwent a 
telephone interview designed to screen for child psychiatric disorders, including ASD. To 
ensure full coverage of child psychiatric disorders, data were also retrieved from population 
based health registers. We investigated the coexistence of eight psychiatric disorders known 
to coexist with ASDs in probands and their co-twins.  
Results 
Half of the individuals with ASDs (50.3%) had four or more coexisting disorders and only 4 
% did not have any concomitant disorder. The “healthy co-twin” in ASD discordant 
monozygotic twin pairs was very often (79% of boys and 50% of girls) affected by at least 
one non-ASD disorder. The corresponding figures for ASD discordant dizygotic twin pairs 
were significantly lower (46% of males and 30% of females).  
Discussion  
Detailed phenotypic descriptions including symptoms of problems associated with a wide 
range of child psychiatric disorders may aid in unraveling the genetic architecture of ASD and 
should guide the development of intervention strategies addressing each problem type 
specifically.  
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Introduction 
Autism Spectrum Disorder (ASD), including the former subgroups Autistic Disorder, 
Asperger´s Disorder and Pervasive Developmental Disorder Not Otherwise Specified, is 
characterized by deficits in social communication and behavioral flexibility (APA, 2013). 
Recent epidemiological studies have shown that ASD affects about 1% of the population 
(Baird et al., 2006).  The direct causes of ASD  remain largely unknown, even when it occurs 
in the presence of a specific genetic syndrome (Coleman & Gillberg, 2012,). However, twin 
studies suggest that up to 80% of the variance in ASD may be referred to genetic influences 
(Folstein & Rutter 1977; Lichtenstein, Carlström, Råstam, Gillberg, & Anckarsäter, 2010).  
In addition, accumulating evidence suggests that ASD shares substantial etiology with other 
developmental disorders. The first twin study of autism (Folstein & Rutter, 1977), reported 
cognitive difficulties, coordination and language deficits, and/or hyperactivity in 5 out of the 7 
monozygotic co-twins considered discordant for ASDs, while only one discordant dizygotic 
co-twin in 10 displayed a delayed motor milestone and another one a learning disability. A 
previous report from the twin study used here demonstrated genetic and environmental effects 
common to ASD and Attention-Deficit/Hyperactivity Disorder (ADHD), Learning 
Disabilities (LDs), Tic Disorders (TDs), and Developmental Coordination Disorder (DCD) 
(Lichtenstein, Carlström, Råstam, Gillberg, & Anckarsäter, 2010). Other studies on ASD 
support the notion of shared etiological factors, Rosenberg et al. (2009), reported data on five 
coexisting disorders in 277 twin pairs, but only on a group-wise basis, meaning that the 
degree of overlap between ASD and specific conditions could not be disentangled. Studies of 
autistic traits usually focus on two characteristics, such as in the case of autistic traits and 
ADHD traits or anxiety traits (Hallett,  Ronald, Rijsdijk, & Happé, 2010 & Ronald, Simonoff, 
Kuntsi, Asherson, & Plomin, 2008). Two review articles focusing only on twin studies 
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(Ronald & Hoekstra 2001; Posthuma & Polderman 2013) are recommended for further 
reading about the etiological overlap between ASD, autistic traits and other disorders.  
In spite of robust behavioral genetic results, molecular studies have shown a far less 
consistent picture. Candidate gene-based association studies and, lately, genome-wide 
association studies (GWAS) on ASD have been inconsistently replicated and generally 
showed small effect sizes (Wang et al., 2009 & Weiss, Arking, Daly, & Chakravarti, 2009). 
The most important obstacle for successful genetic studies in ASDs has generally been 
attributed to the heterogeneity of the ASD phenotype. Indeed this notion is supported by 
studies of rare mutations and Copy Number Variants (CNVs) that have reported associations 
across ASDs and LDs (Betancur, 2011) and ADHD (Leblond et al., 2012). Furthemore, this 
has been illsustrated in  families carrying known rare risk variants (O’Roak et al., 2011; Weiss 
et al., 2008) where carriers of the same genetic aberration may display different phenotypic 
characteristics and neurodevelopmental diagnoses. (Stein et al., 2011 & Ballif et al., 2007) 
In clinical practice, coexisting disorders in ASD are prevalent (Gillberg & Billstedt., 2000 
Simonoff et al., 2008), and have recently come to be regarded as the rule rather than the 
exception (Gillberg, 2010), and to be crucially important for the design of comprehensive 
intervention strategies.  This has led to the proposal of a new concept - ESSENCE for Early 
Symptomatic Syndromes Eliciting Neurodvelopmental Clinical Examinations - linking the 
vast majority of early onset neurodevelopmental disorders together, highlighting the need for 
broad and comprehensive clinical examinations (Gillberg, 2010). One of the rationales behind 
ESSENCE is that most children with neurodevelopmental disorders are impaired in additional 
areas, not just the one domain that pertains to a particular diagnostic label, and that they 
therefore require input from several different specialties. 
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Taken together, accumulating evidence from several avenues of research as well as clinical 
practice indicate that ASD is far from sharply demarcated either at a genotypic or the 
phenotypic level. To better understand ASD, to identify their causes and to treat mental 
health/developmental problems comprehensively, it is essential to understand which other 
disorders that coexist with ASD and what the coexistence/overlap actually means.  
A segment of the current cohort has previously been studied with a view to quantify the 
statistical effects of shared etiology across ASD, ADHD, LD, TD, and DCD (Lichtenstein, 
Carlström, Råstam, Gillberg, & Anckarsäter, 2010).. Here, the occurrence of ASDs and 
coexisting disorders will be presented at the level of the individual so as to better depict the 
complexity of the ASD phenotype in a way that might be informative to clinicians and 
researchers alike. After assessing sibling recurrence rates and heritability of ASD in this 
cohort, we now aimed to (i) characterize, in detail, the ASD-phenotype by simultaneously 
describing eight different possible coexisting mental and physical disorders in proband twins 
with ASD and their co-twins, and (ii) compare the rates of these coexisting disorders in ASD-
discordant monozygotic vs dizygotic co-twins, in order to illustrate the full range of 
phenotypical expressions of shared genetic and environmental effects.   
 
Methods 
Subjects 
All participants were recruited from the ongoing Child and Adolescent Twin Study in Sweden 
(CATSS), which has been described in detail elsewhere (Anckarsäter et al., 2011). Briefly, 
since 2002, parents of all twins turning 9 (for some cohorts 12) years in Sweden, are 
contacted and invited to participate in a telephone interview. Among other measures, the 
interview includes the Autism-Tics, AD/HD and other Comorbidities inventory (A-TAC 
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(Hansson et al 2005, Larson et al., 2010 & Larson et al., 2013)). The response rate in CATSS 
is about 80%, and non-responders differ little from responders with regard to 
neurodevelopmental disorders (Anckarsäter et al., 2011). In addition, the CATSS has been 
linked to Swedish population based registries. For the present study, data from the National 
Patient Register (NPR) was used.  
The present report includes twins born between 31
st
 of June 1992 and 1
st
 of January 2001, 
whose parents have responded for both twins in the CATSS (n=19,130, 51% male). Of those 
responding, 28.2% were MZ, 35.3% DZ same-sex (ss), 34.3% DZ opposite-sex (os), and 
2.2% had unknown zygosity. Zygosity was determined by a panel of 49 single nucleotide 
polymorphisms. When DNA was not available, an algorithm of questions was used, which 
was developed based on the parent responses for 571 twins with known zygosity. Only twins 
with >95% probability of being correctly classified, were assigned zygosity by this method, 
and 420 twins were therefore excluded on the basis that their zygosity was unknown.  
The CATSS study has ethical approval from the Karolinska Institute Ethical Review Board 
(Dnr 03-672 and 2010/507-31/1), and the linkage to registers has also been approved by the 
Ethics Committee at Karolinska Institutet (Dnr 2009-939). 
 
Measures 
Definition of ASD 
ASD was defined in three different ways, (i) through the A-TAC ASD module,  (ii) through 
the NPR, and (iii) by direct questions to parent relating to diagnosis made. 
7 
 
Autism-Tics AD/HD and other Comorbidities inventory (A-TAC) 
The A-TAC is a parent telephone interview, organized into modules covering a broad range of 
neurodevelopmental disorders (Hansson et al., 2005). The A-TAC consists of 96 items that 
are scored “1” for “yes”, 0.5 for “yes, to some extent”, and “0” for “no”.  The A-TAC has 
been validated both cross-sectionally (Larson et al., 2010) and prospectively in a population-
based cohort recalled for later, blinded clinical assessments (Larson et al., 2013). ASD-related 
symptoms are measured by a 17-item ASD module in the A-TAC, including 12 questions 
specifically covering the DSM-IV symptom criteria for autistic disorder (299.00). Out of the 
17 items, six correspond to the language domain, six to the social interaction domain, and five 
to the restricted and repetitive behavior domain of the DSM-IV. The ASD score predicts 
clinical diagnoses of ASDs with an area under the receiver operating characteristics curve of 
>0.90, which has also been shown in an independent validation by a Spanish group (Cubo et 
al., 2011). In this paper, the “diagnostic cut-off” of 8.5 was chosen to create proxies for 
clinical diagnoses of ASD, which yields a sensitivity and specificity of 0.71 and 0.95, 
respectively, and a population prevalence of 0.9% (Larson et al., 2010).  
National Patient Register 
At birth, or upon receiving a citizenship, all people living in Sweden are assigned a personal 
identification number (PIN), which renders linkage across registers possible. The NPR 
encompasses data on all psychiatric inpatient care since 1987 and includes best-estimate 
specialist diagnoses assigned according to ICD versions 9 and 10. Since 2001, the register 
also comprises information from outpatient consultations with specialist physicians. From the 
NPR, information about a diagnosis of ASD was collected. The validity of the register is 
continuously evaluated; in individuals with reported ASD, 96.0% (92.0- 98.4) of diagnoses 
are confirmed when checked against the individual´s medical records (Idring et al., 2012).  
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Diagnostic questions in CATSS 
The CATSS telephone interview also contains specific questions that are worded "has your 
child ever received a diagnosis of Autistic disorder, Asperger´s disorder or Pervasive 
developmental disorder not-otherwise specified"?  
Definition of proband twins with ASD 
ASD was defined by (i) scoring at or above high cut-off (>8.5) on the A-TAC, or (ii) a 
diagnosis of ASDs in the NPR, or (iii) an affirmative answer to the specific questions about a 
diagnosis of an ASD in the CATSS. In total, 272 individuals with ASD were identified (105, 
through A-TAC only, 21, through registers only, 47 through self-report only and 99 through 
combinations of the three). The 47 individuals for whom only the specific question had been 
endorsed had a mean A-TAC score of 5.5 (CI:s 5.0-6.1, compared to the population mean 
0.76, (CI:s 0.74-0.78) and thus corresponded to a “screening diagnosis” of ASDs in the A-
TAC validation study (Larson et al., 2010). When excluding those with unknown zygosity 
(n=12), there remained a total of 260 individuals (proband twins) with ASD, corresponding to 
a population prevalence of 1.4% with a male-female ratio of 3.5:1. 
Definition of coexisting disorders 
Other coexisting disorders were similarly defined through three sources, via the relevant 
“diagnostic module” on the A-TAC, by the NPR and by open diagnostic questions.  
In the A-TAC, screening cutoffs with high sensitivity but lower specificity have been 
validated for LD, ADHD, TD (Larson et al., 2010) and for Oppositional Defiant Disorder 
(ODD, Kerekes et al submitted). Obsessive Compulsive Disorder (OCD) has not been 
included in the validation studies but this module consists of straight-forward questions on the 
DSM-defined phenomena of obsessions and shows good agreement with clinical practice 
(Lundström et al., 2013). Finally, a composite of well known neurodevelopmental problems 
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(motoric, perceptual and executive) were collapsed into one single category, "composite", 
consisting of the validated modules for DCD and/or executive dysfunctions and/or perceptual 
problems (Larson et al., 2010). Distributions, Chronbach´s α and heritability estimates for all 
scales can be found in a previous publication (Anckarsäter et al., 2011).  
Diagnostic questions in CATSS 
In addition to the specific questions about ASD, all parents were asked "does your child have 
any other disorder that we have not asked about". All written responses to this question have 
been surveyed by the last author and categorized based, as far as possible, on presumed 
pathogenesis, for instance chromosomal or brain damage syndromes. 
National Patient Register 
From the NPR register, information about diagnoses of ASD, ADHD, LD, , TD, ODD, OCD, 
chromosomal syndromes (ICD-10 Q85, Q90-99) and brain damage syndromes (ICD-10 G00-
G39, G45-G46, G80-G94, Q00-Q04) were collected.  
ADHD, LD, TD, ODD, OCD and Composite were defined through the A-TAC or the NPR. 
Chromosomal syndromes and brain damage syndromes were defined via the open questions 
in the A-TAC or the NPR. 
Analyses 
Descriptive statistics were calculated on all 19,130 individuals. The 260 ASD proband twins, 
with known zygosity, were then selected, and coexisting disorders were plotted for both 
proband twins and co-twins individually, separately for gender and for MZ, DZ-ss and DZ-os 
twins.. Sibling recurrence rates were defined as the percentage of co-twins meeting criteria for 
ASD and co-twins meeting criteria for other disorders, but not ASD. Kruskal Wallis and 
Mann-Whitney U tests were used to test differences in the mean number of coexisting 
disorders across zygosity.  
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Heritability estimates  
In twin methodology it is possible to disentangle genetic and environmental effects by 
comparing MZ twins who share 100%, and DZ twins, who share 50% of their segregating 
alleles. Generally, the genetic and environmental effects are partitioned into standardized 
variance components: (A) additive genetic effects, (C) shared environmental effects that make 
the twins more similar, and (E) unique environmental effects that make the twins less similar.  
Using only MZ and DZ-ss twins (n = 12,140), tetrachoric correlations and liability threshold 
models were employed to calculate categorical heritability.  All analyses were conducted 
separately for the whole sample and separately for boys and girls. SAS 9.3 and MX were used 
for all analyses.  
Results 
 
Descriptive statistics 
The distribution of the screening diagnoses in the entire CATSS (n=19,130) can be seen in 
Table 1. A total of 272 ASDs screen-positive individuals were identified, yielding a 
population prevalence of 1.4% with a male-female ratio of 3.5:1 (Table 1). 
Sibling recurrence rates and heritability estimates   
The ASD sibling recurrence rate for MZ was 39% for the full sample (46% for boys and 24% 
for girls). The corresponding figures for DZ-ss were 8%, 10% and 4% (figure 1 & 2).   
Univariate heritability estimates based on these figures showed a large genetic component for 
the collapsed sample:.84 (.50-.95), (82 (.40-.1.0) for boys and .84 (.16-1.0) for girls) (table 2). 
When adding other co-existing disorders, the MZ sibling recurrence rate rose to 89% for boys 
and 52% for girls, while the corresponding figures for DZ-ss co-twins were 44% and 30%, 
respectively (figure 1). 
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Coexisting disorders among proband twins with ASD 
Eleven of 260 proband twins (4.2%) had no other coexisting disorder identified, yielding a 
total population prevalence for ASD Only (i.e. ASD without any other disorder) of 5.8 per 
10000 (Table 3, Figure 2). Half (50.3%) had four or more coexisting disorders. The most 
frequent coexisting disorders were ADHD (79.3%) and LD (75.0%), followed by TD 
(36.1%), ODD (36.1%), and OCD (23.8%). Documented brain damage syndromes were 
present in 7.7% of the proband twins and 2.3% had known chromosomal syndromes 
associated with ASD, and 74.6% met criteria for ‘Composite’.  
As expected, the number of coexisting disorders in individuals with ASD did not differ across 
zygosities: male MZ twins with ASD had an average of 3.3 coexisting disorders, female MZ 
3.3, DZ ss male 3.2, DZ-ss female 3.2), DZ-os proband male 3.5 and DZ-os proband female 
3,5 (overall p=.99). 
Coexisting disorders among ASD discordant co-twins 
In 32% of the MZ co-twins who were ASD discordant, there was no disorder, while there was 
one disorder in 68%, and two or more disorders in 52% (Table 3, Figure 2) - most commonly 
ADHD (n=13/42%) and LD (n=13/42%). For 64% of the DZ ASD discordant twins, no 
disorder was reported.  
In the ASD discordant male MZ co-twins, no disorder was reported in 4/19 (21%) (figure 1; 
figure 2). In discordant male DZ-ss co-twins, 38/63 (54%) had none of the coexisting 
disorders.  
In the female MZ co-twins, no disorder was reported in 6/12 (50%), and 19/27 (70%) of the 
DZ-ss discordant female twins had no coexisting disorders.  For os-twins, where the proband 
was male 36/53 (68%) had no coexisting disorder while the corresponding figures for os-
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twins with female probands were 14/25 (56%). The most common disorders in discordant DZ 
twins were LD (38/23%) and ADHD (30/18%). 
With regard to the average number of disorders there was a significant difference between 
MZ (1.7) and DZ-ss (0.7) (p>=.001) and MZ and DZ-os (0.7) (p=.001). No significant 
difference was found between male (1.8) and female (1.6) MZ cotwins (p=.546). Similarly, no 
difference was found as regards the number of coexisting disorders across the four DZ groups 
(p=.67).  
 
DISCUSSION 
The results presented here demonstrate that ASD without coexisting disorders is extremely 
rare. The overall rate for coexisting disorders in individuals (twins) with ASD is at least 95%. 
In addition, MZ co-twins of probands with ASD, who are discordant for ASDs almost always 
have another type of neurodevelopmental disorder. The findings suggest that (a) molecular 
genetic research would benefit from broader phenotyping, and (b) compartmentalization into 
mutually exclusive categories should be avoided in clinical settings. Finally, the visualization 
of sibling recurrence rates paralleled with heritability estimates may be useful for clinicians 
and researchers when interpreting results from articles based on twin methodology.  
The very considerable variety of neurodevelopmental problems found both in proband twins 
with ASD and in their ASD-discordant MZ co-twins suggests that a more accurate (broader) 
phenotype palette is needed in studies aimed at unravelling the biology behind ASD (and 
other neurodevelopmental disorders) than that covering merely one sharply demarcated 
clinical diagnosis. This is supported by the results of several other twin studies reporting 
genetic and environmental overlap between ASD and other neurodevelopmental disorders 
(Ronald & Hoekstra 2001; Posthuma & Polderman 2013). Among the most interesting 
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genetic ASD studies in recent years have focused on rare point mutations and submicroscopic 
variations in chromosomal structure (copy number variations/CNVs), which may be 
associated with a range of neurodevelopmental problems , not just ASD (Neale et al., 2012 & 
Pinto et al., 2010). ”Mild” diagnostic expressions and general susceptibility for 
neurodevelopmental problems may be more influenced by common genetic variants, whereas 
severe forms of ASD with learning disability are more likely to be caused by rare mutations 
(Geschwind, 2011). In addition, studies of Contactin-Associated Protein-like 2 (CNTNAP2), 
one of the major candidate genes for ASD phenotypes, show that rare (Bakkaloglu et al., 
2008) and common (Stein et al., 2011 & Vernes et al., 2008) variants are associated with ASD 
of different severity but also hyperactivity and impulsivity (Strauss et al., 2006) as well as TD 
(Belloso et al., 2007). In this context, by using broad instruments for phenotyping, there might 
be a better chance that Genome Wide Association Studies/GWAS, mutation screening studies 
and CNV microarray investigation may present reliable genetic findings and contribute to the 
understanding of the biology of ASD  
The results presented here support the notion of broad multidisciplinary assessments of Early 
Symptomatic Syndromes Eliciting Neurodevelopmental Examinations/ESSENCE (Gillberg, 
2010) that may guide treatment alternatives. In clinical settings, compartmentalization into 
mutually exclusive categories should be avoided. This may aid in treatment as, for instance, 
social skills training in ASD is affected negatively by the presence of ADHD (Antshel et al., 
2011) and better acquisition of social skills has been noted in children with ASD with a higher 
level of cognitive function compared to those with lower (Ben-Itzchak & Zachor, 2007). 
Additionally, the very high sibling recurrence rate for MZ and DZ co-twins suggests that 
clinicians should always screen for neurodevelopmental problems in co-twins. When 
researchers discuss discordance and concordance meticulous and careful definitions should be 
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used. This becomes evident when utilizing the co-twin control design, where the concept of 
discordance is a key factor. 
Strengths and limitations 
The main strengths of this study include the high response rate in a nationwide study; use of a 
validated instrument for assessment, and the additional linkage to national registries, to 
maximize ascertainment.  
However, our findings must be seen in the light of some limitations. Neither the A-TAC, the 
registries, nor the self-reported questions have perfect sensitivity of specificity, as to why 
some degree of diagnostic misclassification should be expected. On the other hand, clinical 
examinations, which would be preferred, are not feasible in a nation-wide study sample. To 
define co-existing disorders, broad screening diagnoses were used, which inflates the number 
of coexisting disorders. On the other hand, the screening diagnoses are validated to reflect 
dysfunction and severity within each diagnostic area (Larson et al., 2010). The sex differences 
in sibling recurrence rates should be interpreted with caution.  ASD in girls may present itself 
differently (Kopp, Kelly, & Gillberg 2010) and this might also hold true for other 
neurodevelopmental disorders. Thus, the lower sibling recurrence rate in girls might not 
adequately reflect the true degree of recurrence. A difference in the mean number of 
coexisting conditions was found in those who had been picked up as ASD by the A-TAC only 
(3,97, CIs 3.7-4.2) as compared with those who had a registered diagnosis and endorsed the 
open question (3.04, CIs 2.5-3.9). This might reflect parental reporting biases but also the 
severity of ASD, and the findings must therefore be interpreted with caution.         
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Table 1. Descriptive data on 19,130 Swedish twins 
 Zygosity  
 MZ  
(52% ♀) 
DZ-ss  
(46% ♀) 
DZ-os  
(50% ♀) 
Unknown  
(45% ♀) 
Total 
 Yes No Yes No Yes No Yes No Yes % 
ASDs 71 5325 105 6693 84 6486 12 408 272 1.4 
Chromosomal syndromes 3 5393 18 6726 22 6548 2 418 45 0.2 
Brain Damages 82 5314 96 6648 109 6461 11 409 298 1.6 
LDs 791 4593 1071 5664 999 5563 98 321 2959 15.5 
ADHD 479 4894 743 5971 668 5880 62 354 1952 10.2 
OCD 81 5315 128 6616 100 6470 6 414 315 1.7 
TDs 162 5220 221 6505 209 6347 12 406 604 3.2 
ODD 138 5258 228 6516 169 5401 18 402 553 2.9 
Composite 245 5151 396 6349 354 6216 35 385 1030 5.4 
 
MZ= Monozygotic, DZ-ss = Dizygotic same sex, DZ-os = Dizygotic opposite sex, ASDs = 
Autism Spectrum Disorders, Chrom = Chromosomal Syndromes, Brain = Brain Damage, LDs 
= Learning Disabilities, ADHD = Attention Deficit Hyperactivity Disorder, OCD = Obsessive 
Compulsive Disorder, TDs = Tic Disorders, ODD = Oppositional Defiant Disorder, 
Composite = developmental coordination disorder and/or executive dysfunctions and/or 
perceptual problems   
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Table 2. Tetrachoric correlations, proband-wise concordance rates and heritability estimates.  
 
 
 
 
 
 
 
 
 
 
Note: MZ= Monozygotic, DZ= Dizygotic. A = part of the variance explained by genetic 
factors, C = part of the variance explained by shared environmental factors, E = part of 
variance explained by non-shared environmental factors. 
 
 
 
 
 
Correlation (95% CI:s)  dichotomous outcome 
All Boys Girls 
MZ DZ MZ DZ MZ DZ 
.91 
(.85-.97) 
.50 
 (.33-.67) 
.92 
(.86-.99) 
.52  
(.32-.71) 
.87 
(.72 .1.0) 
.37 
(.00-.78) 
Proband-wise concordance rates (95% CI:s) 
.56  
(.41-70) 
.15 
(.07-.27) 
.63 
(.45-.78) 
.18 
(.08-.32) 
.40 
(.14-.69) 
.07 
(.19-.32) 
         
Estimates of genetic and environmental effects (95% CI:s) 
All              Boys                Girls 
A C E A C E A C E 
.84 
(.50-.95) 
.08 
(.00.38) 
.09 
(.04-.17) 
.82 
(.45-.1.0) 
.10 
(.00-.45) 
.08 
(.03-.16) 
.84 
(.16-1.0) 
.00 
(.00-.57) 
.16 
(.05-1.0) 
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Table 3.  
 Note: *= percentage within the category, 
a
= female proband, 
b
= male proband 
ASD= Autism Spectrum Disorders, MZ= Monozygotic, DZ= Dizygotic, SS= Same sex, os= 
Opposite Sex.    
 
 
 
 
 
Number of coexisting disorders in probands and ASD-discordant co-twins 
 ASD  
probands 
MZ 
cotwins 
DZ-ss 
cotwins 
DZ-os  
cotwins
a
 
DZ-os  
cotwins
b
 
Co-existing disorders n %
*
 n %
 *
 n %
 *
 n %
 *
 n %
 *
 
≥6 14 5.4 0 0 0 - 0 - 0 - 
5 40 15,3 1 3,2 1 1,1 1 4,0 2 3,7 
4 77 29.6 5 16,1 3 3,4 0 - 0 - 
3 58 22.3 4 12,9 5 5,6 1 4,0 2 3,7 
2 36 13.8 6 19,4 9 10,1 5 20.0 5 9,4 
1 24 9.2 5 16,1 12 13,4 4 16,0 8 15,1 
0 11 4.2 10 32,2 57 64,0 14 56,0 36 67,9 
Total n 260  31  89  25  53  
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Figure 1, sibling recurrence rates of ASD and other disorders in probands and cotwins 
 
 
Note: ■ = percentage of twin pairs where both individuals have ASDs. ■ = percentage of twin 
pairs where the co-twin display a screening diagnosis of ADHD and/or LD, TDs, OCD, ODD, 
composite, chromosomal syndromes, and/or brain damage syndromes, but not an ASD. ■ = 
No ASDs or coexisting disorders 
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Figure 2. Coexisting disorders in twin pairs concordant or discordant for ASDs   
 Note: Each line in the categories (MZ, DZ, DZ -OS) represents a twin pair. Each square 
under the heading “Probands” or “Co-twins” represent an individual. Each square (to the right 
of “Probands” and left of “Co-twins”) represent coexisting disorders in that individual. 
25 
 
LDs= Learning Disabilities, ADHD=Attention Deficit Hyperactivity Disorder, 
OCD=Obsessive compulsive Disorder, TDs= Tic Disorders, ODD = Oppositional Defiant 
Disorder, Composite= developmental coordination disorder and/or executive dysfunctions 
and/or perceptual problems   
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Supplementary material  
Sources of ascertainment and overlap  
A-TAC Registers Open question Frequency 
0 0 1 47 
0 1 0 21 
0 1 1 25 
1 0 0 105 
1 0 1 42 
1 1 0 7 
1 1 1 25 
 
0 = no recorded ASD, 1= recorded ASD 
